Spine BioPharma, Inc.
Pharmaceuticals · NEW YORK, NY
PharmaceuticalsSEC Form D
Spine BioPharma, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 5, 2026, reporting $384,798 raised toward a $8,500,000 offering.
Incorporated in Delaware and based in NEW YORK, NY, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Spine BioPharma, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Marc R. ViscogliosiExecutive Officer · Director
- Fran MageeExecutive Officer
- Thomas Bumol, PhDDirector
- Frank Cammisa, MDDirector
- John J. ViscogliosiDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised